• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.

作者信息

Giard Jeanne-Marie, Dodge Jennifer L, Yao Francis Y, Mehta Neil

机构信息

Department of Medicine , Université de Montréal , Montreal , Quebec , Canada.

Division of Gastrointestinal and Liver Diseases, Department of Medicine , Keck School of Medicine of University of Southern California , Los Angeles , California , USA.

出版信息

Liver Transpl. 2023 Feb 1;29(2):233-235. doi: 10.1002/lt.26541. Epub 2023 Jan 17.

DOI:10.1002/lt.26541
PMID:35809249
Abstract
摘要

相似文献

1
Alpha-fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha-fetoprotein at liver transplantation.在肝细胞癌肝移植前3个月内甲胎蛋白斜率超过7.5 ng/ml，即使在控制肝移植时的甲胎蛋白水平后，仍可预测复发。
Liver Transpl. 2023 Feb 1;29(2):233-235. doi: 10.1002/lt.26541. Epub 2023 Jan 17.
2
Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.甲胎蛋白斜率>7.5ng/ml/月预测肝癌肝移植后微血管侵犯和肿瘤复发。
Transplantation. 2018 May;102(5):816-822. doi: 10.1097/TP.0000000000002094.
3
Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.肝切除术后肝细胞癌复发时间及甲胎蛋白是挽救性肝移植的重要预后因素。
Liver Transpl. 2014 Sep;20(9):1057-63. doi: 10.1002/lt.23919.
4
A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.一种新型预后列线图可准确预测肝移植后肝细胞癌复发：对865例连续肝移植受者的分析
J Am Coll Surg. 2015 Apr;220(4):416-27. doi: 10.1016/j.jamcollsurg.2014.12.025. Epub 2014 Dec 27.
5
Excessive intraoperative blood loss independently predicts recurrence of hepatocellular carcinoma after liver transplantation.术中失血过多是肝移植后肝细胞癌复发的独立预测因素。
BMC Gastroenterol. 2015 Oct 15;15:138. doi: 10.1186/s12876-015-0364-5.
6
Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.影响活体肝移植后肝细胞癌复发患者生存的预后因素：特别关注中性粒细胞/淋巴细胞比值。
Transplantation. 2013 Dec 15;96(11):1008-12. doi: 10.1097/TP.0b013e3182a53f2b.
7
Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C-related cirrhosis with occult hepatocellular carcinoma: a case report.丙型肝炎相关肝硬化合并隐匿性肝细胞癌原位肝移植术后13年发生肝细胞癌肝内复发：1例报告
Liver Transpl. 2012 May;18(5):612-4. doi: 10.1002/lt.23412.
8
Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.基于甲胎蛋白和 C 反应蛋白的血清学风险指数预测晚期肝细胞癌患者无效肝移植。
Dig Dis Sci. 2019 Jan;64(1):269-280. doi: 10.1007/s10620-018-5296-9. Epub 2018 Sep 27.
9
Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.肝移植后肝细胞癌复发的治疗益处及欧美大型系列研究中生存预后因素分析
Ann Surg Oncol. 2015 Jul;22(7):2286-94. doi: 10.1245/s10434-014-4273-6. Epub 2014 Dec 4.
10
Validation of the α-fetoprotein Model for Hepatocellular Carcinoma Recurrence After Transplantation in an Asian Population.验证甲胎蛋白模型在亚洲人群肝移植后肝癌复发中的应用。
Transplantation. 2018 Aug;102(8):1316-1322. doi: 10.1097/TP.0000000000002136.

引用本文的文献

1
Japanese living donor liver transplantation criteria for hepatocellular carcinoma: nationwide cohort study.日本活体供肝肝移植治疗肝细胞癌标准的全国性队列研究。
BJS Open. 2024 Jul 2;8(4). doi: 10.1093/bjsopen/zrae079.